Roivant Sciences Ltd [NASDAQ: ROIV] slipped around -0.2 points on Tuesday, while shares priced at $14.74 at the close of the session, down -1.34%.
Roivant Sciences Ltd stock is now 23.66% up from its year-to-date (YTD) trading value. ROIV Stock saw the intraday high of $15.0288 and lowest of $14.72 per share. The company’s 52-week high price is 16.05, which means current price is +68.84% above from all time high which was touched on 09/17/25.
Compared to the average trading volume of 6.61M shares, ROIV reached a trading volume of 8027374 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Roivant Sciences Ltd [ROIV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $19.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Roivant Sciences Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 02, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on July 10, 2025, representing the official price target for Roivant Sciences Ltd stock. Previously, the target price had yet another raise to $17, while Wolfe Research analysts kept a Outperform rating on ROIV stock.
The Price to Book ratio for the last quarter was 2.31, with the Price to Cash per share for the same quarter was set at 6.60.
How has ROIV stock performed recently?
Roivant Sciences Ltd [ROIV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.95. With this latest performance, ROIV shares gained by 23.66% in over the last four-week period, additionally plugging by 36.10% over the last 6 months – not to mention a rise of 24.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ROIV stock in for the last two-week period is set at 70.46, with the RSI for the last a single of trading hit 0.51, and the three-weeks RSI is set at 0.44 for Roivant Sciences Ltd [ROIV]. The present Moving Average for the last 50 days of trading for this stock 12.34, while it was recorded at 15.02 for the last single week of trading, and 11.32 for the last 200 days.
Roivant Sciences Ltd [ROIV]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Roivant Sciences Ltd [ROIV] shares currently have an operating margin of -5104.73% and a Gross Margin at 96.33%. Roivant Sciences Ltd’s Net Margin is presently recorded at -2111.79%.
Roivant Sciences Ltd (ROIV) Capital Structure & Debt Analysis
According to recent financial data for Roivant Sciences Ltd. ( ROIV), the Return on Equity (ROE) stands at -15.84%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -13.44%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Roivant Sciences Ltd’s Return on Invested Capital (ROIC) is -11.06%, showcasing its effectiveness in deploying capital for earnings.
Roivant Sciences Ltd (ROIV) Efficiency & Liquidity Metrics
Based on Roivant Sciences Ltd’s (ROIV) latest financial statements, the Debt-to-Equity Ratio is 0.02%, indicating its reliance on debt financing relative to shareholder equity.
Roivant Sciences Ltd (ROIV) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Roivant Sciences Ltd. (ROIV) effectively leverages its workforce, generating an average of -$654173.33 per employee. The company’s liquidity position is robust, with a Current Ratio of 40.54% and a Quick Ratio of 40.54%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Roivant Sciences Ltd [ROIV]
With the latest financial reports released by the company, Roivant Sciences Ltd posted -0.3/share EPS, while the average EPS was predicted by analysts to be reported at -0.24/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.06. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ROIV.
Insider trade positions for Roivant Sciences Ltd [ROIV]
There are presently around $76.80%, or 103.98%% of ROIV stock, in the hands of institutional investors. The top three institutional holders of ROIV stocks are: SB INVESTMENT ADVISERS (UK) LTD with ownership of 71.36 million shares, which is approximately 9.6983%. VIKING GLOBAL INVESTORS LP, holding 69.16 million shares of the stock with an approximate value of $$730.98 million in ROIV stocks shares; and VIKING GLOBAL INVESTORS LP, currently with $$705.23 million in ROIV stock with ownership which is approximately 9.0674%.
